Sep 2, 2026 07:00AM
Jun 5, 2026 08:59AM
Apr 30, 2026 03:23PM
Jan 8, 2026 03:37AM
Dec 31, 2025 12:19PM
Aug 27, 2025 07:00AM
Jul 3, 2025 06:39AM Morgan Stanley Assumes Axsome Therapeutics (AXSM) at Overweight
Aug 27, 2024 07:00AM
Aug 23, 2024 11:30AM
Apr 29, 2024 03:56AM
Dec 12, 2023 05:35PM
Sep 5, 2023 07:00AM
Feb 22, 2023 07:01AM
Feb 22, 2023 07:00AM Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe
Feb 22, 2023 07:00AM
Sep 6, 2022 07:00AM
Sep 6, 2022 07:00AM
Aug 19, 2022 09:18AM
May 6, 2022 02:38PM
Apr 25, 2022 08:54AM
Jan 19, 2022 07:40AM Axsome Therapeutics (AXSM) Responds to FDA's CMC Deficiency Questions in 8K - Morgan Stanley
Sep 14, 2021 09:28AM
Aug 10, 2021 08:49AM
Sep 8, 2020 07:00AM
Sep 8, 2020 07:00AM
Apr 27, 2020 09:30AM
Mar 12, 2020 07:00AM
Mar 12, 2020 07:00AM Axsome Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Dec 23, 2019 04:19PM
Dec 23, 2019 04:19PM
Dec 19, 2019 07:06AM
Dec 19, 2019 07:05AM
Dec 19, 2019 07:05AM
Sep 3, 2019 07:00AM
Sep 3, 2019 07:00AM Axsome Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
Aug 8, 2019 07:00AM
Aug 8, 2019 07:00AM
Feb 26, 2018 09:26AM

226,767 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All